Throttling back the heart's molecular motor
- 5 February 2016
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 351 (6273) , 556-557
Abstract
A small molecule inhibits mutated forms of myosin that cause cardiac hypertrophy [Also see Report by Green et al. ]Keywords
Funding Information
- NIH (HL059408, HL126909)
This publication has 15 references indexed in Scilit:
- A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in miceScience, 2016
- Molecular Mechanics of Cardiac Myosin-Binding Protein C in Native Thick FilamentsScience, 2012
- Understanding Cardiomyopathy Phenotypes Based on the Functional Impact of Mutations in the Myosin MotorCirculation Research, 2012
- In the Thick of ItCirculation Research, 2011
- Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart FailureScience, 2011
- Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletionTrends in Genetics, 2003
- Single-Molecule Mechanics of R403Q Cardiac Myosin Isolated From the Mouse Model of Familial Hypertrophic CardiomyopathyCirculation Research, 2000
- Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1993
- Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.Circulation, 1992
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationCell, 1990